March 2006
 |
| Features |
 |


 |
| CME CAD/Angina |
 |
|
 |
 |
Acute Coronary Syndromes and Women: A New Era |
| |
by John Pfeifer, MD • Richard M. Steingart, MD |
| |
Weill Medical College of Cornell University and 2Memorial Sloan-Kettering Cancer Center, New York, NY |
 |
 |
| |
Commentary |
 |
Women and Acute Coronary Syndromes |
| |
by Marian C. Limacher, MD |
 |
 |
 |
| CME Pharmacotherapy in Women |
 |
|
 |
 |
Pharmacotherapy for Chroniccardiovascular Disease in Women |
| |
by Verena Stangl, MD • Nicoline Jochmann, MD • Karl Stangl, MD |
| |
Med. Klinik mit Schwerpunkt Kardiologie, Angiologie, Pneumologie, Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Germany |
 |
 |
| |
Commentary |
 |
Pharmacotherapy for Chronic Cardiovascular Disease |
| |
by Stephen P. Glasser, MD |
 |
 |
 |
| Stroke |
 |
|
 |
 |
Body mass index and risk of strokein women |
| |
by Tobias Kurth, MD, ScD • Julie E. Buring, ScD |
| |
Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts |
 |
 |
| |
Commentary |
 |
Association Between Stroke Risk and Body Mass Index in Women |
| |
by Richard E. Stewart, MD |
 |
 |
 |
| Cardiac Surgery and Depression |
 |
|
 |
 |
Sex, Depression, and Health Outcomes After Coronary Artery Bypass Graft Surgery |
| |
by Susmita Mallik, MD, MPH, MS • Viola Vaccarino, MD, PhD |
| |
Department of Medicine, Emory University, Atlanta, Georgia |
 |
 |
| |
Commentary |
 |
Depression and Coronary Artery Disease in Women |
| |
by Joan K. Cohn, DSW |
 |
 |
| |
Case Report |
 |
Improved Retinopathy in a Patient With Type 1 Diabetes: a Review of the Role for Hmg-coa Reductase Inhibitors in the Treatment of Diabetic Retinopathy |
| |
by John A. Tayek, MD • James Hong, MD • Jose Canales, MD |
| |
Harbor-UCLA Medical Center, Torrance, California |
 |
 |
| |
Commentary |
 |
HMG-CoA Reductase Inhibitors and Diabetic Retinopathy |
| |
by Fadi El Baba, MD |
 |
|
 |
 |
 |
 |
 |

 |
| Departments |
 |

|
|
|
 |
|